BOTHELL, Wash.--(BUSINESS WIRE)--Acucela Inc., a clinical-stage biotechnology company discovering new drug therapies for eye diseases, today announced that Ryo Kubota, M.D., Ph.D., president and chief executive officer, will present at the annual C21 BioVentures Conference in Napa, California, at 11:30 a.m. EDT on May 21, 2008. Dr. Kubota will provide the audience with a general update on Acucela’s progress in its clinical and preclinical-stage programs.
